Headline
The latest stories from AHA Today.
The Food and Drug Administration authorized for emergency use the first prescription antibody test that allows individuals to collect a finger-stick dried blood sample at home for analysis at a Symbiotica laboratory when a health care provider deems it appropriate.
The Moderna COVID-19 vaccine continued to protect 33 healthy adults six months after receiving the second dose, according to an ongoing clinical trial examining the vaccine’s durability, published in the New England Journal of Medicine.
The AHA unveiled several new resources to aid hospitals’ and health systems’ efforts to increase the public’s confidence in COVID-19 vaccines.
The Federal Emergency Management Agency announced additional assistance under its public assistance program for eligible costs to safely reopen and operate certain private nonprofits in response to the COVID-19 emergency, including private nonprofit medical facilities.
All U.S. adults will become eligible for the COVID-19 vaccine by April 19, President Biden announced. That’s a couple weeks sooner than the May 1 target he announced last month.
Join the AHA and its American Organization for Nursing Leadership April 7 at 1 p.m. ET for a panel discussion on ways to identify and address inequities in maternal care, empower women of color and create solutions to improve maternal health equity.
The Centers for Medicare & Medicaid Services released a toolkit for qualified health plans applying for plan year 2022 certification, and guidance to help applicants identify essential community providers and meet network adequacy standards.
The FBI and Cybersecurity and Infrastructure Security Agency advised organizations to protect their computer networks from known vulnerabilities in FortiOS, the operating system for the Fortinet network security system.
Johnson & Johnson will soon start testing its COVID-19 vaccine candidate in U.S. adolescents, the company announced.
The Biden-Harris administration sent Congress its first-year drug policy priorities, as required by each new administration.